Inventor · name-matched record
SWAIN NIGEL ALAN
2 granted patents·3 pending applications·0 citations·filing 2021–2025
20Inventor score
Files withNXERA PHARMA UK LTD5
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
5 records- 0167US2026015314A1Prostaglandin ep4 receptor antagonist compoundsNXERA PHARMA UK LTD·Filed 2025·Application pending·0 cites
- 0266US2026085056A1Ox1 receptor antagonistsNXERA PHARMA UK LTD·Filed 2025·Application pending·0 cites
- 0360US2026042745A1Pyrrolidine-2-carboxamide derivatives as prostaglandin e2 receptor 4 (ep4) agonists for the treatment of gastrointestinal and pulmonary diseasesNXERA PHARMA UK LTD·Filed 2023·Application pending·0 cites
- 0452US12552799B2Triazolone compoundsNXERA PHARMA UK LTD·Filed 2021·Granted Feb 17, 2026·0 cites·7 claims
- 0551US12528815B25-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancerNXERA PHARMA UK LTD·Filed 2021·Granted Jan 20, 2026·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when SWAIN NIGEL ALAN files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →